ABBOTT LABORATORIES PAYS OUT USD1.5 BILLION IN NON-COMPLIANCE CASE
October 1st, 2012
BY LEAH GERMAIN
A US district court judge has ordered global pharmaceutical manufacturer Abbott Laboratories Inc. to pay USD1.5 billion for illegally marketing its prescription drug, Depakote, for uses not approved by the US Food and Drug Administration (FDA).
According to the US Department of Justice, Abbott advertised Depakote to treat dementia and schizophrenia in ways not confirmed by the FDA.
The Illinois-based manufacturer must now pay a USD500 million fine, USD198.5 million in forfeitures and undergo five years' probation where its CEO and directors ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.